Loading: 100%
GILEAD SCIENCES INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 9,000 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker GILDno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 176066727884
datesClosing price (adj.)
13.10.201781.17
11.10.201782.57
04.10.201782.42
27.09.201783.86
20.09.201782.63
13.09.201783.15
06.09.201782.43
30.08.201780.72
23.08.201773.28
16.08.201772.89
09.08.201773.44
02.08.201775.36
26.07.201773.72
19.07.201772.26
12.07.201769.36
05.07.201770.42
27.06.201770.22
20.06.201765.18
13.06.201764.23
06.06.201763.91
30.05.201763.58
23.05.201763.77
16.05.201764.79
09.05.201766.65
02.05.201767.62
25.04.201766.17
18.04.201765.12
11.04.201765.08
04.04.201766.03
28.03.201766.15
21.03.201766.78
14.03.201766.81
07.03.201767.52
28.02.201768.95
21.02.201767.79
14.02.201766.09
07.02.201771.54
31.01.201770.88
24.01.201768.73
17.01.201770.35
10.01.201773.38
03.01.201772.55
27.12.201672.13
19.12.201672.79
12.12.201671.43
05.12.201670.35
28.11.201672.47
21.11.201672.90
14.11.201674.62
07.11.201671.94
31.10.201671.58
24.10.201672.09
17.10.201670.62
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
81.17n/a
Market Capitalisation
in million USD
106,067n/a
Enterprise Value
in million USD
120,994n/a
Common Shares Outstanding
as per Apr 28, 2017
1,306,728,398n/a
Preferred Shares Outstanding
as per Apr 28, 2017
n/a
Average Basic Shares Outstanding
TTM
1,320,250,000n/a
Average Diluted Shares Outstanding
TTM
1,335,000,000n/a
Index Membership
n/a
Business Summary
Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.
no data available
Key Financials & Ratios (all figures TTM as per Dec 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 30,390n/a
Gross Profit 26,129n/a
Operating Income 17,633n/a
EBITDA 18,791n/a
Net Profit 13,501n/a
Balance Sheet
Cash and Cash Equivalents 11,895n/a
Receivables 4,514n/a
Total Current Assets 20,445n/a
PP&E 2,865n/a
Total Assets 56,977n/a
Accounts Payable 1,206n/a
Current Debt 0n/a
Total Current Liabilities 9,219n/a
Long-Term Debt 26,346n/a
Total Liabilities 37,614n/a
Total Equity 19,363n/a
Cash Flow
Depreciation & Amortisation 1,158n/a
Change in Working Capital 1,362n/a
Operating Cash Flow 16,669n/a
Net Change in PP&E and Intangibles -748n/a
Investing Cash Flow -11,985n/a
Dividends Paid -2,455n/a
Financing Cash Flow -9,347n/a
Total Change in Cash -4,622n/a
Free Cash Flow 15,796n/a
Profitability Ratios
Gross Margin 86.0%n/a
Operating Margin 58.0%n/a
Net Profit Margin 44.4%n/a
Return on Equity 69.7%n/a
Return on Assets 23.7%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 6.44n/a
EV/Sales 3.98n/a
Book to Market Value 0.18n/a
Other Ratios
Current Ratio 221.8%n/a
Liabilities to Equity Ratio 194.3%n/a
Debt to Assets Ratio 46.2%n/a
Profit & Loss StatementP&L data quality: 50% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
4,230
5,336
7,011
7,949
8,385
9,702
11,202
24,890
32,639
30,390
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
0
Cost of revenue
769
1,127
1,596
1,870
2,124
-2,471
-2,859
-3,788
-4,006
-4,261
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
4,999
6,463
8,607
9,819
10,510
7,231
8,343
21,102
28,633
26,129
Other Operating Income
0
0
0
0
0
0
0
0
0
0
Operating Expenses
1,297
1,519
1,887
2,117
2,471
-3,221
-3,819
-5,837
-6,440
-8,496
Selling, General & Administrative
706
797
947
1,044
1,242
-1,461
-1,699
-2,983
-3,426
-3,398
Selling & Marketing
0
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
0
Research & Development
591
722
940
1,073
1,229
-1,760
-2,120
-2,854
-3,014
-5,098
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
6,296
7,982
10,494
11,937
12,981
4,010
4,524
15,265
22,193
17,633
Non-Operating Income (Loss)
47
-6
-27
-49
-139
-398
-316
-409
-534
-536
Interest Expense, net
-63
-65
-70
-109
-205
-361
-307
-412
-688
-964
Interest Expense
0
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
110
59
42
60
67
-37
-9
3
154
428
Pretax Income (Loss), Adjusted
6,342
7,976
10,466
11,888
12,842
3,612
4,208
14,856
21,659
17,097
Abnormal Gains (Losses)
0
-11
0
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
6,342
7,965
10,466
11,888
12,842
3,612
4,208
14,856
21,659
17,097
Income Tax (Expense) Benefit, net
-635
-702
-876
-1,024
-862
-1,038
-1,151
-2,797
-3,553
-3,609
Current Income Tax
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
5,707
7,263
9,590
10,864
11,980
2,574
3,057
12,059
18,106
13,488
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
5,707
7,263
9,590
10,864
11,980
2,574
3,057
12,059
18,106
13,488
Minority Interest
9
9
10
12
15
18
18
42
2
13
Net Income
5,716
7,272
9,600
10,876
11,995
2,592
3,075
12,101
18,108
13,501
Preferred Dividends
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
5,716
7,272
9,600
10,876
11,995
2,592
3,075
12,101
18,108
13,501
Remarks
restated on Mar 1, 2010 n/a
calculated values,
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 23, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 25, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
1,790
1,657
2,099
9,900
1,862
2,132
10,128
14,607
11,895
Cash & Cash Equivalents
n/a
1,459
1,273
908
9,884
1,804
2,113
10,027
12,851
8,229
Short Term Investments
n/a
331
384
1,191
16
59
19
101
1,756
3,666
Accounts & Notes Receivable
n/a
1,023
1,390
1,622
1,951
1,751
2,182
4,635
5,854
4,514
Accounts Receivable, Net
n/a
1,023
1,390
1,622
1,951
1,751
2,182
4,635
5,854
4,514
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
0
Inventories
n/a
928
1,052
1,204
1,390
1,745
1,697
1,386
1,955
1,587
Raw Materials
n/a
0
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
537
714
784
677
798
986
1,565
2,346
2,449
Prepaid Expenses
n/a
270
352
388
469
451
564
1,057
1,518
1,592
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
141
295
279
208
263
331
508
828
857
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
126
67
116
0
84
91
0
0
0
Total Current Assets
n/a
4,278
4,813
5,708
13,919
6,156
6,997
17,714
24,762
20,445
Property, Plant & Equipment, Net
n/a
529
700
701
774
1,100
1,166
1,674
2,276
2,865
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
1,450
2,248
3,219
64
720
439
1,598
11,601
20,485
Long Term Investments
n/a
0
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
680
1,938
1,964
2,546
13,263
13,977
13,678
13,077
13,182
Intangible Assets
n/a
123
1,525
1,426
1,063
11,736
11,900
11,073
10,247
8,971
Goodwill
n/a
0
0
0
1,004
1,061
1,169
1,172
1,172
1,172
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
227
101
153
144
131
190
236
324
402
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
330
312
385
335
335
718
1,197
1,334
2,637
Total Noncurrent Assets
n/a
2,658
4,886
5,885
3,384
15,083
15,582
16,950
26,954
36,532
Total Assets
n/a
6,937
9,699
11,593
17,303
21,240
22,579
34,664
51,716
56,977
Liabilities and owners' equity
Payables & Accruals
n/a
1,172 1172398000
1,743 1743323000
1,715 1715430000
2,439 2438553000
2,965 2965245000
3,599 3599000000
5,144 5144000000
8,468 8468000000
9,017 9017000000
Accounts Payable
n/a
601 601200000
811 810544000
803 803025000
1,206 1206052000
1,327 1327339000
1,256 1256000000
955 955000000
1,178 1178000000
1,206 1206000000
Accrued Taxes
n/a
45 44757000
168 167623000
2 1862000
41 40583000
13 13403000
11 11000000
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
526 526441000
765 765156000
911 910543000
1,192 1191918000
1,625 1624503000
2,332 2332000000
4,189 4189000000
7,290 7290000000
7,811 7811000000
Short Term Debt
n/a
6 5631000
6 5587000
646 646345000
2 1572000
1,169 1169490000
2,697 2697000000
483 483000000
982 982000000
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
43 42963000
123 122721000
103 103175000
75 74665000
103 103162000
111 111000000
134 134000000
440 440000000
202 202000000
Deferred Revenue
n/a
43 42963000
123 122721000
103 103175000
75 74665000
103 103162000
111 111000000
134 134000000
440 440000000
202 202000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
1,221 1220992000
1,872 1871631000
2,465 2464950000
2,515 2514790000
4,238 4237897000
6,407 6407000000
5,761 5761000000
9,890 9890000000
9,219 9219000000
Long Term Debt
n/a
1,098 1098025000
1,155 1155443000
2,839 2838573000
7,606 7605734000
7,055 7054555000
3,939 3939000000
11,921 11921000000
21,073 21073000000
26,346 26346000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
152 152231000
166 166327000
167 167270000
315 315261000
404 403664000
488 488000000
1,163 1163000000
1,640 1640000000
2,049 2049000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
74 74181000
43 43026000
33 32844000
32 31870000
21 20532000
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
10 10190000
83 83000000
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
78 78050000
123 123301000
134 134426000
283 283391000
373 372942000
405 405000000
1,163 1163000000
1,640 1640000000
2,049 2049000000
Total Noncurrent Liabilities
n/a
1,250 1250256000
1,322 1321770000
3,006 3005843000
7,921 7920995000
7,458 7458219000
4,427 4427000000
13,084 13084000000
22,713 22713000000
28,395 28395000000
Total Liabilities
n/a
2,471 2471248000
3,193 3193401000
5,471 5470793000
10,436 10435785000
11,696 11696116000
10,834 10834000000
18,845 18845000000
32,603 32603000000
37,614 37614000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
3,931 3931019000
4,378 4377551000
4,649 4649088000
4,904 4903896000
5,643 5643463000
5,388 5388000000
2,393 2393000000
445 445000000
455 455000000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
300 300314000
1,995 1995272000
1,184 1183730000
1,777 1776760000
3,705 3704744000
6,106 6106000000
12,732 12732000000
18,001 18001000000
18,154 18154000000
Other Equity
n/a
41 41240000
-6 -5758000
31 30911000
58 58200000
-46 -45615000
-124 -124000000
301 301000000
88 88000000
278 278000000
Equity Before Minority Interest
n/a
4,273 4272573000
6,367 6367065000
5,864 5863729000
6,739 6738856000
9,303 9302592000
11,370 11370000000
15,426 15426000000
18,534 18534000000
18,887 18887000000
Minority Interest
n/a
193 193010000
138 138093000
258 258108000
128 128493000
241 241130000
375 375000000
393 393000000
579 579000000
476 476000000
Total Equity
n/a
4,466 4465583000
6,505 6505158000
6,122 6121837000
6,867 6867349000
9,544 9543722000
11,745 11745000000
15,819 15819000000
19,113 19113000000
19,363 19363000000
Total Liabilities & Equity
n/a
6,937 6936831000
9,699 9698559000
11,593 11592630000
17,303 17303134000
21,240 21239838000
22,579 22579000000
34,664 34664000000
51,716 51716000000
56,977 56977000000
Remarks restated on n/a restated on Mar 1, 2010 n/a restated on Feb 28, 2011 n/a restated on Feb 23, 2012 n/a restated on Feb 27, 2013 n/a restated on Feb 25, 2014 n/a restated on Feb 25, 2015 n/a restated on Feb 24, 2016 n/a restated on Feb 27, 2017 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 92% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
1,576
1,970
2,626
2,890
2,789
2,574
3,057
12,059
18,106
13,488
Net Income
0
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
101
156
213
265
302
278
345
1,050
1,098
1,158
Non-Cash Items
324
146
211
359
336
235
265
227
-34
661
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
-332
-128
30
-680
212
108
-562
-518
1,159
1,362
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
1,669
2,143
3,080
2,834
3,639
3,195
3,105
12,818
20,329
16,669
Change in Fixed Assets & Intangibles
-79
-115
-230
-62
-132
-397
-190
-557
-747
-748
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-1,177
-53
-738
-1,785
4,310
-697
315
-1,266
-11,728
-11,237
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-46
-11
-1,248
-91
-589
-10,752
-379
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-1,302
-179
-2,216
-1,938
3,590
-11,846
-254
-1,823
-12,475
-11,985
Dividends Paid
0
0
0
0
0
0
0
0
-1,874
-2,455
Cash From (Repayment of) Debt
-99
-4
-311
2,612
3,973
305
-4,440
3,153
8,905
3,312
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-244
-1,723
-776
-3,801
-2,171
-201
-269
-5,018
-9,683
-10,793
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
0
Other Financing Activities
173
253
35
-149
-38
459
2,165
-1,160
-2,311
589
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-171
-1,475
-1,051
-1,339
1,764
563
-2,544
-3,025
-4,963
-9,347
Net Cash Before Disc. Operations and FX
196
490
-187
-443
8,992
-8,088
307
7,970
2,891
-4,663
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
0
Net Cash Before FX
196
490
-187
-443
8,992
-8,088
307
7,970
2,891
-4,663
Effect of Foreign Exchange Rates
-44
1
1
77
-17
8
2
-56
-67
41
Net Changes in Cash
152
491
-186
-365
8,976
-8,080
309
7,914
2,824
-4,622
Remarks
restated on Mar 1, 2010 n/a
calculated values,
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 23, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 25, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo